Martin Smith

Martin Smith boasts extensive experience in the pharmaceutical and biotechnology sectors, currently serving in US Commercial Operations at Cycle Pharmaceuticals since 2023. Prior to this role, Martin held the position of CEO at 5qRx.oi from April 2020 to January 2023, focusing on optimized intelligence solutions. An accomplished member of the executive team at Claritas Rx, Martin has also been deeply involved in consulting and leadership roles at ZS Associates, where various positions spanned from Associate to Practice Area Leader in Biotech Consulting. Martin's earlier experience includes semiconductor and microelectronics research at Toshiba Research Europe and Koninklijke Philips Electronics, respectively, along with a foundation in graphic design and sales. An academically accomplished individual, Martin earned a PhD in Quantum Physics from the University of Cambridge and multiple MBAs from prestigious institutions, enhancing expertise in commercial operations and analytics.